secwatch / observer
8-K filed March 15, 2024, 7:59 PM ET ticker PEPG CIK 0001835597
other confidence low sentiment neutral materiality 0.20

PepGen amends bylaws to update proxy rules and stockholder meeting procedures

PepGen Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PepGen Inc.: Adopted second amended and restated bylaws to revise advance notice provisions, address universal proxy rules, update technical changes, and clarify meeting procedures and exclusive jurisdiction (effective 2024-03-15).

Change
bylaw amendment
Effective
2024-03-15
Exact text from the filing
On March 15, 2024, the board of directors (the “Board”) of PepGen Inc. (the “Company”) approved and adopted the second amended and restated by-laws (the “Second Amended and Restated By-laws”) of the Company, effective immediately. The Second Amended and Restated By-laws amend certain of the provisions of Article I, Sections 2, 6, 8, and 9, and Article VI, Sections 8 and 9. Among other things, the amendments set forth in the Second Amended and Restated By-laws: (1) revise the procedures and disclosure requirements set forth in the advance notice by-law provisions; (2) address the universal proxy rules adopted by the U.S. Securities and Exchange Commission, by clarifying that no person may solicit proxies in support of a director nominee other than the Board’s nominees unless such person has complied with Rule 14a-19 under the Securities Exchange Act of 1934, as amended (“Rule 14a-19”), including applicable notice and solicitation requirements; (3) require that a stockholder directly or
View on SEC.gov

188 governance changes filed in the last 30 days. Browse all governance changes →

PepGen Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-069110
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.